Related Experiment Video

Updated: May 15, 2026

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
08:01

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow

Published on: November 4, 2016

Case study interpretation-New Orleans: case 5. Blastic plasmacytoid dendritic cell neoplasm

Christine G Roth1, Lisa J Robinson

  • 1Division of Hematopathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Cytometry. Part B, Clinical Cytometry
|January 4, 2013
PubMed
Summary

No abstract available in PubMed .

Keywords:
CD123CD4+/CD56+acute leukemiablastic plasmacytic dendritic cell neoplasmflow cytometry

More Related Videos

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
13:34

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors

Published on: March 17, 2014

Related Experiment Videos

Last Updated: May 15, 2026

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
08:01

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow

Published on: November 4, 2016

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
13:34

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors

Published on: March 17, 2014

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Articles linked to this work by shared authors, journal, and citation graph.

Promoting functional independence and reducing the risk of hospital-associated deconditioning for acutely hospitalised older adults: a group concept mapping service evaluation.

Disability and rehabilitation·2025

Molecular Regulation of Bone Turnover in Juvenile Idiopathic Arthritis: Animal Models, Cellular Features and TNFα.

Frontiers in bioscience (Landmark edition)·2024

Preclinical evaluation of ELP-004 in mice.

Pharmacology research & perspectives·2024

A group concept mapping and ethnographic study of intensive care rehabilitation culture.

Nursing in critical care·2024

The calcium channel Orai1 is required for osteoblast development: Studies in a chimeric mouse with variable in vivo Runx-cre deletion of Orai-1.

PloS one·2023

Identifying and prioritising the key components of a Quality Improvement Network for allied health professionals and psychological therapists: a group concept mapping project.

BMJ open quality·2023

Subtype-specific immunophenotypic and cytogenetic patterns complement flow-cytometric detection of measurable residual disease in B-lymphoblastic leukemia.

Cytometry. Part B, Clinical cytometry·2026

Extended routine lymphocyte immunophenotyping refines individual immune organization across a heterogeneous patient cohort.

Cytometry. Part B, Clinical cytometry·2026

Cytoplasmic staining of T cell receptor components enables efficient assessment of lineage and clonality in surface CD3-negative T cell neoplasms.

Cytometry. Part B, Clinical cytometry·2026

Platelet flow cytometry: An evolving platform for clinical hematology.

Cytometry. Part B, Clinical cytometry·2026

Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B-cell acute lymphoblastic leukemia: A report from The Cytometry Society, India.

Cytometry. Part B, Clinical cytometry·2026

CD72 as a complementary B-lineage marker for longitudinal measurable residual disease surveillance after CD19 CAR-T therapy in R/R B-ALL.

Cytometry. Part B, Clinical cytometry·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us